SCHEMBL6999877

SCHEMBL6999877

Cc1ccnc2cc(C(=O)O)ccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.50
DYRK1A Q13627 1/20 0.49
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 3/20 0.46
KDM4C Q9H3R0 3/20 0.46
ALDH1A1 P00352 2/20 0.46
MAPT P10636 2/20 0.46
KDM5A P29375 2/20 0.46
KDM5B Q9UGL1 2/20 0.46
KDM6B O15054 2/20 0.46
KDM5C P41229 2/20 0.46
KDM2A Q9Y2K7 2/20 0.46
KDM3A Q9Y4C1 2/20 0.46
TET3 O43151 1/20 0.46
KDM4A O75164 1/20 0.46
BBOX1 O75936 1/20 0.46
ASPH Q12797 1/20 0.46
KDM4D Q6B0I6 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4641324 0.86 TDP1 (0.50) TDP1DYRK1ANPC1RAB9ASMN1; SMN2
SCHEMBL487232 0.81 KDM4E (0.47) TDP1DYRK1ANPC1RAB9ASMN1; SMN2
SCHEMBL2810092 0.81 LMNA (0.50) TDP1DYRK1ANPC1RAB9AKDM4E
SCHEMBL1732368 0.79 SMYD3 (0.49) TDP1DYRK1AKDM4EKDM4CALDH1A1
SCHEMBL437621 0.79 NR4A2 (0.54) TDP1DYRK1AKDM4EKDM4CALDH1A1
SCHEMBL31175317 0.76 CYP1A2 (0.55) TDP1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL21816246 0.76 CYP1A2 (0.55) TDP1NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL16447569 0.76 TDP1 (0.54) TDP1DYRK1ANPC1RAB9ASMN1; SMN2
SCHEMBL21218143 0.75 MET (0.58) KDM4EALDH1A1MAPTHPGDGAA
SCHEMBL13544381 0.75 TDP1 (0.49) TDP1NPC1RAB9ASMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1140944-B1 EPOTHILONE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS NOVARTIS AG (CH) 2003-08-27 EP disclosed
US-6387927-B1 WATER SOLUBILITY NOVATIS AG (CH) 2002-05-14 US disclosed
EP-1140944-A1 EPOTHILONE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS Novartis AG (CH) 2001-10-10 EP disclosed
WO-2000037473-A1 EPOTHILONE DERIVATIVES AND THEIR USE AS ANTITUMOR AGENTS NOVARTIS AG (CH) 2000-06-29 WO disclosed